Bruker Corp (BRKR) Upgraded to Outperform by Wolfe Research
Wolfe Research upgrades Bruker Corp (BRKR) to Outperform from Peer Perform.
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Bruker Corp.
Last Updated: Dec 11, 2025, 11:40 PM · Source: Finnhub.io
Wolfe Research upgrades Bruker Corp (BRKR) to Outperform from Peer Perform.
Goldman Sachs initiates coverage on Bruker Corp (BRKR) with a Sell rating.